CIMETIDINE 5% / IBUPROFEN 2% / SALICYLIC ACID 17%
CIMETIDINE 5% / IBUPROFEN 2% / SALICYLIC ACID 17%
Approved
Approval ID
891a69a7-e004-c8c5-e053-2995a90ab49e
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 17, 2019
Manufacturers
FDA
Sincerus Florida, LLC
DUNS: 080105003
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
CIMETIDINE 5% / IBUPROFEN 2% / SALICYLIC ACID 17%
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code72934-1047
Product Classification
G
Generic Name
CIMETIDINE 5% / IBUPROFEN 2% / SALICYLIC ACID 17%
Product Specifications
Route of AdministrationTOPICAL
Effective DateMay 17, 2019
FDA Product Classification
INGREDIENTS (3)
IBUPROFENActive
Quantity: 2 g in 100 g
Code: WK2XYI10QM
Classification: ACTIB
SALICYLIC ACIDActive
Quantity: 17 g in 100 g
Code: O414PZ4LPZ
Classification: ACTIB
CIMETIDINEActive
Quantity: 5 g in 100 g
Code: 80061L1WGD
Classification: ACTIB